9999999997-15-009681.txt : 20150515 9999999997-15-009681.hdr.sgml : 20150515 20150514143830 ACCESSION NUMBER: 9999999997-15-009681 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150515 DATE AS OF CHANGE: 20150514 20150514 20150514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Loxo Oncology, Inc. CENTRAL INDEX KEY: 0001581720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462996673 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-36562 FILM NUMBER: 15862140 BUSINESS ADDRESS: STREET 1: 1 LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-658-4749 MAIL ADDRESS: STREET 1: 1 LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``+VPPRH@!&(61@X&I#% MF*&8@:&1@9N!?97!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@ M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)= M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH- M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9IV M&#S!@5,0(@+.@%$:P,T-N3_JAT1+K%Q/":SJM1&EJ83^DZ:C2HU1#$CM_+P566[O<8Z*;E33C7B+"2S7.X:\'Q;X71:'5>C((A@ MY%%A^J.F<*P*67ZVNH4L%+$:H[#R93*:5OEV MGEI]HFNE-WNRJ.I"YE;TY$H2IJ)O6N;99E+N<@64)%H5/\UW#EU_:(LEU]E! M5S7Y-6C%-CJ5C4*;2^GORTVUS-RL>4,`14+E%LK5`>^[ZS$U'O&02AU;DHM-^[X?*YU3?^W>HDO(WD=HSU M6H=M_>MK\0O_QX^*C^'W+GG^!?(B?AUX'V6.TVN8.PVD#.?;U)V?AN\\9,Z2 MUI*#Q.'K]UD,=9T\L@1V7*&'LSPG[320,,P\W#%J5]>0.F3Y_#_I*N`#G66] MY_"?``,`/[6&6`T*96YDA10CFD$WO!"TB2O%_TB._31&VR@]?!#^=Q,4^GKA>2Q)G` MRO4XB9W4)=09I>;JU%X$]\_TZ\"+2!SS@)NL*D"MRS(PSU/CL`#6^` M^;A&1TDY.=UT*0LG271!N!?!MR(\+"?3)=RYWA`#7XX6Z7QQA]P6,TV*,A*& MF(1^-[.[.3.[YY,I[AA]AW0Y':7W.+%:X<:(7X3#>MG5B>F7*?1BH4Q3*PZ, MQBD\S(`F@=*>.:$%Q#R$'T1*4=/D,CFTC]7(][UY:^"ASINJ>3[F)OV9E)6#1$$!<+XAXQ-0J]&UH?)MHVR80,$:&$7`>$U\;U\!= M-3C#/(8G2W\X'HQG+B=#Y[>`!3PX6G!XJH+SU[4/G/-1N;"^#=\+Q#_/372T MFC4RN!Z+N7]5M':/S")G_>(.T>1EUXD"LAJRW:XJ\ZPKFQK,BKH0$I9[U(OI M>;CV&$CQ&2-_4&UP=.68BZ*S/$HDX% MG11FV+VX"?[@/3#K&E5CL2.AK/L+%+^E66<8EAV(M]Q`N1Y6^[X0QO,)"="Z M?B]-W-.AEDX!&]FHV+D#W5;`]&U;KLNNA:Z!#&:-M/>H[WV##;JEZ(O"(%]S M&A*ZSV2^!1:;^C;61$6D]NL14S<(L5.BA;CUB&UL#[`1;[TP0R#?X\G M/,IK6X#.:;?-.OPJ6Z69"8%9I7[NLZK5%` MF!J9JWDC48\ZJ_7$B,UUV_-_Z<,CF]"RV6M3*=UG4HBB,?>@V:`W+Y9:U?EY M9[W6&D9Y=P,<'LF*C`G6(7MRUD_NDQ,^N3?ZK$GY3]DJ3#Q']YN(L%/>1\_V M4HP;N6NDX3'3,0O8HCZ%Z(0THI0U9K%N.N4;2]6@7G\(4$-UMU]CE54'*,HV MKYI6H),)P"C/&UE@*568=31VA78N#-681!$_:>+T3%E\[EBYE*MUL)NFJII7 M59;"6/O):9_X'UA4\\*2J1F<)':AATMS6WP<2$ MYYK$=J7)HMVW$[)L"L.AW8E<>;'X?&P9E_T:6\K'SU%=2,.8.[9PL5`)BNMZ M=.AS=8]&C#O=5C;[YRU.`RQ'?9EA[9U6*>-6D_,CK[^%7/'B#6LMVG]7&=?H=0J-\^.)18.:> M,]WF]]VVD65W^-RWIC=A@^Q\(D MM)KISTKD4G29/&@C_=(2IVW4#*;IX%\!!@`:N)HN#0IE;F1S=')E86T-96YD M;V)J#3$@,"!O8FH-/#PO1FEL=&5R+T9L871E1&5C;V1E+T9I7!E+T]B:E-T;3X^R`(L'Z+G9V``$&`(V%"#<-"F5N9'-T7!E+UA-3"]4>7!E+TUE M=&%D871A/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5- M,$UP0V5H:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB M861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,BUC M,#`Q(#8S+C$S.30S.2P@,C`Q,"\P.2\R-RTQ,SHS-SHR-B`@("`@("`@(CX* M("`@/')D9CI21$8@>&UL;G,Z&UL;G,Z9&,](FAT='`Z+R]P M=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M(#,R M,S4S+D]21$52/"]R9&8Z;&D^"B`@("`@("`@("`@(#PO&UP.D-R96%T;W)4;V]L/@H@("`@ M("`@("`\>&UP.DUO9&EF>41A=&4^,C`Q-2TP-2TQ-%0Q-#HS-SHQ-BTP-#HP M,#PO>&UP.DUO9&EF>41A=&4^"B`@("`@(#PO&UP34TZ26YS=&%N8V5)1#YU=6ED.F-E M9C@W961B+38U8V0M-#,R,BUA9CEA+6%F.6%E,V8V,&8Y9CPO>&UP34TZ26YS M=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ' M5!:DZ@7!E+UA2968O M5ULQ(#(@,5T^/G-T')E9@T*,3$V#0HE)45/1@T* ` end